{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T12:39:05Z","timestamp":1779885545441,"version":"3.53.1"},"reference-count":26,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2005,7,5]],"date-time":"2005-07-05T00:00:00Z","timestamp":1120521600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[2005,8]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> The relationship between subclinical hypothyroidism (SH) and cardiovascular disease (CVD) is still under debate. The purpose of the present study was to evaluate plasma total homocysteine (tHcy), high sensitive C\u2010reactive protein (hsCRP), small dense low\u2010density lipoprotein (sdLDL), <jats:sc>l<\/jats:sc>\u2010arginine and asymmetric dimethylarginine (ADMA) concentrations and their relationship to nitric oxide (NO) production, measured as plasma nitrite\u2010plus\u2010nitrate (NO<jats:sub>x<\/jats:sub>) concentration, in patients with SH before and after thyroxine replacement therapy and compared with control group values.<\/jats:p><jats:p><jats:bold>Design\u2002<\/jats:bold> Eighty\u2010four women with SH and 33 healthy women as controls matched to the patient group for sex, age and body mass index (BMI), were enrolled in this study. Lipoprotein profile, tHcy, hsCRP, sdLDL, ADMA, <jats:sc>l<\/jats:sc>\u2010arginine and NO<jats:sub>x<\/jats:sub> were measured in pre\u2010 and post\u2010treatment blood samples.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> The pretreatment total cholesterol (TC), LDL\u2010C, hsCRP, ADMA and <jats:sc>l<\/jats:sc>\u2010arginine levels were significantly higher and NO<jats:sub>x<\/jats:sub> levels were lower than in the control group. After treatment, hsCRP, ADMA and <jats:sc>l<\/jats:sc>\u2010arginine levels were significantly reduced and sdLDL and NO<jats:sub>x<\/jats:sub> levels were significantly increased.<\/jats:p><jats:p><jats:bold>Conclusion\u2002<\/jats:bold> The present study demonstrated an elevation of hsCRP and ADMA plasma levels of patients with SH associated with a reduction in NO production, which may contribute to some cardiovascular alterations. The elevated ADMA and hsCRP levels were reduced after thyroxine replacement. Also the sdLDL levels of SH patients were found to be lower than the control group values whereas TC and LDL were elevated. Even though we found an elevation in sdLDL levels after treatment, those values were still not higher than in the control group.<\/jats:p>","DOI":"10.1111\/j.1365-2265.2005.02326.x","type":"journal-article","created":{"date-parts":[[2005,7,25]],"date-time":"2005-07-25T04:54:38Z","timestamp":1122267278000},"page":"203-206","source":"Crossref","is-referenced-by-count":44,"title":["The effects of thyroxine replacement on the levels of serum asymmetric dimethylarginine (ADMA) and other biochemical cardiovascular risk markers in patients with subclinical hypothyroidism"],"prefix":"10.1111","volume":"63","author":[{"given":"Omer","family":"Ozcan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erdinc","family":"Cakir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halil","family":"Yaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emin Ozgur","family":"Akgul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kivilcim","family":"Erturk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeynel","family":"Beyhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cumhur","family":"Bilgi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Kemal","family":"Erbil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,7,5]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(97)89462-4"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03343631"},{"key":"e_1_2_5_4_2","doi-asserted-by":"crossref","first-page":"4585","DOI":"10.1210\/jcem.86.10.7959","article-title":"Subclinical hypothyroidism is mild thyroid failure and should be treated","volume":"86","author":"McDermott M.T.","year":"2001","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"e_1_2_5_5_2","first-page":"270","article-title":"Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam study","volume":"132","author":"Hak A.E.","year":"2000","journal-title":"Archives of International Medicine"},{"key":"e_1_2_5_6_2","first-page":"155","article-title":"The development of ischemic heart disease in relation to autoimmune thyroid disease in a 20\u2010year follow\u2010up study of an English community","volume":"6","author":"Vanderpump M.P.","year":"1996","journal-title":"Thyroid"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)90865-Z"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1988.03410130125037"},{"key":"e_1_2_5_9_2","doi-asserted-by":"crossref","first-page":"2842S","DOI":"10.1093\/jn\/134.10.2842S","article-title":"Asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, explains the \u2018l\u2010arginine paradox\u2019 and acts as a novel cardiovascular risk factor","volume":"134","author":"Boger R.H.","year":"2004","journal-title":"Journal of Nutrition"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.5551\/jat.11.265"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0378-4347(87)80438-3"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.D300007-JLR200"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-4347(96)00531-2"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/41.6.892"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.101.9.948"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.101.16.1899"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1161\/hc4601.099485"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-030039"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1089\/thy.1996.6.505"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199512073332302"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-020905"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2004.05.016"},{"issue":"4","key":"e_1_2_5_23_2","first-page":"262","article-title":"Cardiovascular risk factors in middle\u2010aged women with subclinical hypothyroidism","volume":"25","author":"Luboshitzky R.","year":"2004","journal-title":"Neuro Endocrinology Letters"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9150(02)00372-6"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199704033361401"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200003233421202"},{"key":"e_1_2_5_27_2","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1210\/jcem.87.3.8165","article-title":"Narrow individual variations in serum T(4) and T(3) in normal subjects: a clue to the understanding of subclinical thyroid disease","volume":"87","author":"Andersen S.","year":"2002","journal-title":"Journal of Clinical Endocrinology and Metabolism"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2265.2005.02326.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2265.2005.02326.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T19:00:46Z","timestamp":1697223646000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2265.2005.02326.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7,5]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["10.1111\/j.1365-2265.2005.02326.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2265.2005.02326.x","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,7,5]]}}}